Bradley Foster & Sargent’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-622
| Closed | -$201K | – | 534 |
|
|
2025
Q3 | $201K | Hold |
622
| – | – | ﹤0.01% | 532 |
|
|
2025
Q2 | $242K | Buy |
622
+87
| +16% | +$35K | ﹤0.01% | 500 |
|
|
2025
Q1 | $233K | Buy |
+535
| New | +$215K | ﹤0.01% | 440 |
|
|
2024
Q4 | – | Sell |
-601
| Closed | -$313K | – | 469 |
|
|
2024
Q3 | $313K | Sell |
601
-6
| -1% | -$3.21K | 0.01% | 406 |
|
|
2024
Q2 | $329K | Sell |
607
-25
| -4% | -$13.2K | 0.01% | 397 |
|
|
2024
Q1 | $328K | Hold |
632
| – | – | 0.01% | 390 |
|
|
2023
Q4 | $298K | Buy |
632
+1
| +0.2% | +$462 | 0.01% | 392 |
|
|
2023
Q3 | $280K | Hold |
631
| – | – | 0.01% | 395 |
|
|
2023
Q2 | $280K | Sell |
631
-199
| -24% | -$91.8K | 0.01% | 395 |
|
|
2023
Q1 | $382K | Sell |
830
-6
| -0.7% | -$2.85K | 0.01% | 355 |
|
|
2022
Q4 | $429K | Sell |
836
-375
| -31% | -$190K | 0.01% | 343 |
|
|
2022
Q3 | $550K | Sell |
1,211
-323
| -21% | -$155K | 0.02% | 298 |
|
|
2022
Q2 | $740K | Hold |
1,534
| – | – | 0.02% | 269 |
|
|
2022
Q1 | $754K | Buy |
1,534
+174
| +13% | +$79.5K | 0.02% | 292 |
|
|
2021
Q4 | $630K | Sell |
1,360
-16
| -1% | -$6.73K | 0.01% | 303 |
|
|
2021
Q3 | $513K | Buy |
1,376
+163
| +13% | +$61.9K | 0.01% | 299 |
|
|
2021
Q2 | $463K | Hold |
1,213
| – | – | 0.01% | 313 |
|
|
2021
Q1 | $435K | Sell |
1,213
-7
| -0.6% | -$2.25K | 0.01% | 306 |
|
|
2020
Q4 | $392K | Buy |
1,220
+53
| +5% | +$16.3K | 0.01% | 311 |
|
|
2020
Q3 | $313K | Buy |
+1,167
| New | +$314K | 0.01% | 295 |
|
|
2020
Q1 | $265K | Sell |
1,167
-6
| -0.5% | -$1.64K | 0.01% | 293 |
|
|
2019
Q4 | $354K | Buy |
1,173
+6
| +0.5% | +$1.65K | 0.01% | 304 |
|
|
2019
Q3 | $280K | Hold |
1,167
| – | – | 0.01% | 303 |
|
|
2019
Q2 | $329K | Buy |
1,167
+47
| +4% | +$12.8K | 0.01% | 294 |
|
|
2019
Q1 | $321K | Hold |
1,120
| – | – | 0.01% | 297 |
|
|
2018
Q4 | $294K | Hold |
1,120
| – | – | 0.01% | 295 |
|
|
2018
Q3 | $307K | Hold |
1,120
| – | – | 0.01% | 319 |
|
|
2018
Q2 | $267K | Hold |
1,120
| – | – | 0.01% | 334 |
|
|
2018
Q1 | $246K | Buy |
1,120
+7
| +0.6% | +$1.64K | 0.01% | 328 |
|
|
2017
Q4 | $250K | Buy |
1,113
+50
| +5% | +$10.6K | 0.01% | 326 |
|
|
2017
Q3 | $202K | Buy |
+1,063
| New | +$202K | 0.01% | 351 |
|
Other funds holding ELV
Bradley Foster & Sargent's ELV Position: Q4 2025 in Review
Bradley Foster & Sargent sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 622 shares — an estimated $201K sold.
Bradley Foster & Sargent first reported a position in ELV in Q3 2017 and held it in 31 quarters. The position peaked at $754K in Q1 2022. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.
- Bradley Foster & Sargent reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
- Bradley Foster & Sargent sold 622 Elevance Health shares in Q4 2025, an estimated $201K.
- Bradley Foster & Sargent first reported a position in Elevance Health in Q3 2017 and held it in 31 quarters.
- Bradley Foster & Sargent's Elevance Health position peaked at $754K in Q1 2022.
- 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.
Based on Bradley Foster & Sargent's 13F filing for Q4 2025, filed 12 Feb 2026.